Search for:

News
Life
UK
Finance
Tech
London
UK 2026

prostate

Prostate cancer drug abiraterone will be offered to high-risk patients in England after NHS approval expands access to the life-extending treatment, ending years of postcode inequality and saving lives.

What we know about the NHS policy change expanding prostate cancer drug abiraterone in England

About us
Legal Notice
Contacts
Advertise

© 2025 — 2026 Westminster Pimlico News. All rights reserved.
Content may be reproduced only with a direct, active hyperlink to the original article on westminsterpimliconews.co.uk.

News
Life
UK
Finance
Tech
London
UK 2026

About us
Legal Notice
Contacts
Advertise